A group of HEMLIBRA ambassadors attend HFA symposium 2022
Having the support of people who understand hemophilia A can make a big difference. Our ambassadors are people like you who decided to make the switch to HEMLIBRA. They’re here to help.
Ambassadors are compensated for their participation.
— Matt, 52-year-old man with hemophilia A without factor VIII inhibitors, Washington
Local and national hemophilia events can be great opportunities to connect with the community. You can hear directly from our ambassadors and learn more about HEMLIBRA. Find out about our upcoming in-person and virtual events here.
Check out our Facebook page! Hear stories and connect with community members who have already given HEMLIBRA a shot.
Our Hemophilia Community Clinical Education Managers, or CEMs, have years of nursing/clinical experience and can help answer questions about HEMLIBRA. Many of our CEMs have a personal connection to hemophilia A. Sign up for support.
CEMs do not provide medical advice.
More resources about HEMLIBRA are available for download.
Individual results may vary. Not all patients in the clinical trials had zero bleeds. See results for clinical trial patients with or without factor VIII inhibitors here.
The HEMLIBRA community members shown have been compensated for their participation.
When starting HEMLIBRA, a “loading dose” is taken once weekly for 4 weeks. After that, HEMLIBRA offers 3 regular dosing options: once weekly, once every 2 weeks, or once every 4 weeks. Talk to a doctor about dosing.
Connect with a CEM that will tailor their support to your needs to help you navigate your HEMLIBRA journey.
Link to Healthcare Professionals Site
The information contained in this section of the site is intended for U.S. healthcare professionals only. Click "OK" if you are a healthcare professional.
Link to Third-Party Site
The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control. Genentech does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.